These compounds may interact with:

Nucleotide-binding oligomerization domain-containing protein 1

Potentially involved in: carcinoma; crohn's disease; blau syndrome; progressive relapsing multiple sclerosis; colitis; x-linked lymphoproliferative syndrome 2; inflammatory bowel disease 9; inflammatory bowel disease 5; gastritis; inflammatory bowel disease 1; sarcoidosis; nervous system disorder; glioblastoma; lung carcinoma; subependymal giant cell astrocytoma; nervous system diseases

Disease data sourced from Pharos.